var data={"title":"Kindler syndrome","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Kindler syndrome</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/kindler-syndrome/contributors\" class=\"contributor contributor_credentials\">Cristina Has, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/kindler-syndrome/contributors\" class=\"contributor contributor_credentials\">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/kindler-syndrome/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/kindler-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 06, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H131800537\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Kindler syndrome (KS, MIM# 173650), also known as Weary-Kindler syndrome, is a rare autosomal recessive type of epidermolysis bullosa characterized by skin blistering, photosensitivity, progressive poikiloderma (the combination of skin atrophy, telangiectasias, and pigmentary changes), extensive skin atrophy, and squamous cell carcinomas of skin and mucosal membranes. It was first described in 1954 by Theresa Kindler and considered a poikilodermatous disorder until 2008, when it was classified as a distinct type of epidermolysis bullosa [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. As the first genetic cutaneous disorder associated with alterations in a protein of focal adhesions, KS and its pathogenesis became an important model for understanding the role of focal adhesions in the skin.</p><p>This topic will discuss the pathogenesis, clinical features, diagnosis, and management of Kindler syndrome. Other types of inherited epidermolysis bullosa are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Diagnosis of epidermolysis bullosa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Overview of the management of epidermolysis bullosa&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H131800543\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence and prevalence of Kindler syndrome are unknown. The disease occurs worldwide and affects both sexes and all ethnic groups. More than 170 cases have been reported in the literature so far (<a href=\"https://grenada.lumc.nl/LOVD2/mendelian_genes/variants.php?action=view_all&amp;token=4YQ9Z5FUp70OHSrvIBc62i6d/wOHHZJM2uIBPyJ0yLJ4qaPHdypQ3cA8RtguYoAJPXPjx6vHGYRUlpLAKdgR5r1D//HsQm15qJXu37HaWfmvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=15510\" target=\"_blank\" class=\"external\">Leiden Open Variation Database [LOVD]</a>). Like all autosomal recessive conditions, it is more prevalent in populations with a high degree of consanguineous marriages and in isolates, such as Iran or Panama [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p class=\"headingAnchor\" id=\"H131800549\"><span class=\"h1\">PATHOGENESIS</span></p><p class=\"headingAnchor\" id=\"H71742176\"><span class=\"h2\">Kindlin-1 protein</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Kindler syndrome is caused by mutations in the kindlin-1 gene (<em>FERMT1</em>, MIM #607900) [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/4,5\" class=\"abstract_t\">4,5</a>]. Kindlin-1 is an intracellular adaptor protein of the integrin-linked adhesion sites, known as focal adhesions in cells in culture (<a href=\"image.htm?imageKey=DERM%2F103177\" class=\"graphic graphic_figure graphicRef103177 \">figure 1</a>). Functionally, focal adhesions represent supramolecular signaling and actin-anchoring platforms.</p><p>In human adult tissues, kindlin-1 is expressed in tissues of ectodermal and endodermal origin, in particular in the skin, periodontal tissues, intestinal epithelium, and kidneys [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/4,6,7\" class=\"abstract_t\">4,6,7</a>]. In the skin and oral mucosa, kindlin-1 is localized in basal epidermal keratinocytes in a polarized manner facing the basement membrane [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/8\" class=\"abstract_t\">8</a>]. In the colon and rectum, kindlin-1 is localized to the plasma membrane of the epithelial cells, colocalized with ezrin and beta-catenin [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/9\" class=\"abstract_t\">9</a>]. Together with talin, kindlins directly bind the beta-subunit cytoplasmic tails of integrins and are responsible for integrin activation and trafficking [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/10-12\" class=\"abstract_t\">10-12</a>].</p><p>In Kindler syndrome, skin-disorganized keratinocytes lose their proper architecture, polarization, and adhesion to the dermis [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/8\" class=\"abstract_t\">8</a>]. In vitro, loss of kindlin-1 is associated with abnormal cell shape, modification of the cortical actin network, and increased plasticity of the plasma membrane; functionally, cell adhesion, spreading, and directed motility are perturbed [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/8,11,13\" class=\"abstract_t\">8,11,13</a>]. In immortalized human keratinocytes, kindlin-1 was necessary for mediating epidermal growth factor (EGF)-induced activation signals, including integrin beta-1 activation, focal adhesion kinase&nbsp;(FAK) phosphorylation, and actin reorganization, which finally led to enhanced cell proliferation and migration. These results indicate that kindlin-1 is essential in EGF-induced re-epithelialization in skin wound healing [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/14\" class=\"abstract_t\">14</a>].</p><p>A particular characteristic of Kindler syndrome is epidermal atrophy associated with minimal proliferation of basal keratinocytes and strongly impaired survival of keratinocytes in culture [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/8\" class=\"abstract_t\">8</a>]. The underlying mechanisms include involvement of kindlin-1 in mitotic spindle formation and control of stem cell proliferation [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p>Several studies have shed some light on the molecular mechanisms underlying photosensitivity in Kindler syndrome: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a mouse model study, <em>FERMT1</em> knockdown impaired DNA repair, as indicated by the increased detection of gamma-H2AX and cyclobutane pyrimidine dimers 24 hours after ultraviolet B (UVB) radiation [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/17\" class=\"abstract_t\">17</a>]. Kindlin-1 deficiency sensitized keratinocytes to cytokine and ultraviolet (UV)-induced nuclear factor (NF)-kappa-B and c-Jun N-terminal kinase activation, while genetic or pharmacologic c-Jun N-terminal kinase inhibition and NF-kappa-B inhibition markedly reduced cyclobutane pyrimidine dimers-positive cells [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/17\" class=\"abstract_t\">17</a>]. &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Proinflammatory cytokines interleukin (IL)-1-beta, IL-6, and tumor necrosis factor (TNF)-alpha are upregulated in Kindler syndrome skin and in UVB-irradiated Kindler syndrome keratinocytes [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/18\" class=\"abstract_t\">18</a>]. Expression of these cytokines depends on p38 activation, which is increased in the absence of kindlin-1 and by increased levels of reactive oxygen species. Low levels of kindlin-1 are sufficient to rescue this feature, while overexpression of kindlin-2 has no compensatory effect [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/19\" class=\"abstract_t\">19</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Kindlin-1 is required to fully activate extracellular signal-regulated kinase (ERK) signalling after oxidative damage, and ERK activation protects cells from DNA damage following oxidative stress [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p>The pathogenesis of dermal fibrosis resulting from lack of kindlin-1 has been clarified, at least in part. Kindlin-1-deficient keratinocytes respond to cell stress (eg, ultraviolet irradiation) by upregulating the expression of proinflammatory and profibrotic cytokines such as IL-20, IL-24, transforming growth factor (TGF)-beta-2, platelet-derived growth factor-beta (PDGFB), connective tissue growth factor (CTGF), and matrix metalloproteinases [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/13,21\" class=\"abstract_t\">13,21</a>]. These cytokines initiate an inflammatory response in the dermis, resulting in the activation of fibroblasts and their differentiation to myofibroblasts, which secrete and deposit increased amounts of extracellular matrix proteins [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/21\" class=\"abstract_t\">21</a>]. Repeated cycles of epidermal cell stress, cytokine secretion, dermal inflammation, and profibrotic processes underlie the mucocutaneous fibrosis in Kindler syndrome [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/21\" class=\"abstract_t\">21</a>].</p><p class=\"headingAnchor\" id=\"H131800555\"><span class=\"h2\">Genetics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Kindler syndrome is inherited in an autosomal recessive manner. <em>FERMT1</em> mutations are found in patients in a homozygous or compound heterozygous state. The molecular pathology is complex, and in addition to a few recurrent mutations (eg, c.676dup), many families bear their &quot;private&quot; mutations [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/22\" class=\"abstract_t\">22</a>]. <em>FERMT1</em> mutations are distributed over the entire gene, spanning exons, introns, and the promoter region. The mutation types include nonsense mutations, small deletions, and insertions leading to frameshift and premature termination codons and absence of the protein. Splice-site mutations may have the same outcome or allow the expression of truncated polypeptides [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/23\" class=\"abstract_t\">23</a>]. In addition, large deletions, promoter mutations, and deep intronic mutations have been described [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/3,24-26\" class=\"abstract_t\">3,24-26</a>]. Kindler syndrome seems to be genetically homogeneous.</p><p class=\"headingAnchor\" id=\"H131800561\"><span class=\"h1\">CLINICAL MANIFESTATIONS AND NATURAL HISTORY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The main clinical features of Kindler syndrome are skin blistering, photosensitivity, extensive skin atrophy, and poikiloderma (the combination of skin atrophy, telangiectasias, and pigmentary changes). The phenotype is progressive during the patient's life. In adults, the main cutaneous findings are poikiloderma and mucocutaneous scarring, leading to stenoses of the esophagus and genitourinary tract, ectropion, and webbing of fingers.</p><p class=\"headingAnchor\" id=\"H131800567\"><span class=\"h2\">Skin lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin blistering is usually present at birth and shows an acral distribution (<a href=\"image.htm?imageKey=DERM%2F103491\" class=\"graphic graphic_picture graphicRef103491 \">picture 1</a>). It persists during childhood, but the tendency to develop blisters decreases with age. Blisters have no characteristic features to allow the distinction from other types of epidermolysis bullosa. Initially, they heal without scarring, but skin atrophy develops over time.</p><p>The severity of photosensitivity is variable and seems to be independent of the skin phototype [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/27\" class=\"abstract_t\">27</a>]. Most patients experience mild or unnoticeable photosensitivity.</p><p>Skin atrophy beginning on the dorsal aspects of the hands and feet is recognizable as early as at the age of one to two years (<a href=\"image.htm?imageKey=DERM%2F103492\" class=\"graphic graphic_picture graphicRef103492 \">picture 2</a>) and is a valuable clue for the diagnosis of Kindler syndrome. Skin atrophy extends progressively to the entire integument. Poikiloderma can be first recognized around the age of 10 years, first localized to sun-exposed areas and later disseminated on the entire body surface (<a href=\"image.htm?imageKey=DERM%2F103494\" class=\"graphic graphic_picture graphicRef103494 \">picture 3</a>).</p><p>Many adults with Kindler syndrome have dry skin and develop diffuse keratoses of hands and feet. On this background, dermatophyte infections such as tinea pedis are common. Sclerotic features of the hands and feet such as webbing, sclerodermiform appearance of fingers, or pseudoainhum (constrictions of the fingers) (<a href=\"image.htm?imageKey=DERM%2F103496\" class=\"graphic graphic_picture graphicRef103496 \">picture 5B</a>) manifest in young adults with significant variability, probably related to the extent of exposure to environmental factors.</p><p>Loss of dermatoglyphics mirrors skin atrophy (<a href=\"image.htm?imageKey=DERM%2F103497\" class=\"graphic graphic_picture graphicRef103497 \">picture 4</a>); patients should be aware of this feature.</p><p class=\"headingAnchor\" id=\"H131800573\"><span class=\"h2\">Hair and nail changes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Scalp hair is not changed, but adults with Kindler syndrome have sparse body hair. Nail dystrophy is common and may accompany the sclerosis of the fingers and pseudoainhum (<a href=\"image.htm?imageKey=DERM%2F103498%7EDERM%2F103496\" class=\"graphic graphic_picture graphicRef103498 graphicRef103496 \">picture 5A-B</a>). Onychomycosis may also be associated.</p><p class=\"headingAnchor\" id=\"H131800585\"><span class=\"h2\">Mucosal lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucosal fragility is very common in patients with Kindler syndrome [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/28\" class=\"abstract_t\">28</a>]. The oral mucosa is most frequently affected, with mechanically induced bleeding and erosions and early and severe periodontitis that may lead to premature loss of teeth (<a href=\"image.htm?imageKey=DERM%2F103568\" class=\"graphic graphic_picture graphicRef103568 \">picture 6</a>) [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/29,30\" class=\"abstract_t\">29,30</a>]. (See <a href=\"topic.htm?path=periodontal-disease-in-children-associated-systemic-conditions\" class=\"medical medical_review\">&quot;Periodontal disease in children: Associated systemic conditions&quot;</a>.)</p><p>Most young adults with Kindler syndrome suffer from progressive dysphagia and esophageal strictures requiring repeated dilatations. Intestinal involvement (ie, colitis induced by epitheliolysis) has been reported in a few cases [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/9,31,32\" class=\"abstract_t\">9,31,32</a>].</p><p>Anal, urogenital, and ocular mucosa involvement is also common [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/31\" class=\"abstract_t\">31</a>]. Urethral stenosis can occur in male patients during childhood or later in life [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/28,33,34\" class=\"abstract_t\">28,33,34</a>]. Vaginal stenosis and effacement of the external female genitals have been reported in female patients [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/33,35\" class=\"abstract_t\">33,35</a>].</p><p>Patients with ocular involvement may develop ectropion and recurrent keratoconjunctivitis resulting in symblepharon [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/28,36\" class=\"abstract_t\">28,36</a>].</p><p class=\"headingAnchor\" id=\"H131800591\"><span class=\"h2\">Mucocutaneous malignancies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with Kindler syndrome have an increased risk of developing mucocutaneous squamous cell carcinomas. In a cohort of 62 European patients with Kindler syndrome, 10 patients, three of whom were younger than 45 years, developed a squamous cell carcinoma [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/31\" class=\"abstract_t\">31</a>]. The most frequently involved sites are the extremities, lips, and oral mucosa. Despite a well-differentiated histopathology, these tumors have an aggressive behavior, with a tendency to recur and metastasize [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/37\" class=\"abstract_t\">37</a>].</p><p class=\"headingAnchor\" id=\"H131800597\"><span class=\"h2\">Revertant mosaicism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with Kindler syndrome due to specific <em>FERMT1</em> mutations demonstrate a particular, disseminated pattern of revertant mosaicism (<a href=\"image.htm?imageKey=DERM%2F103618\" class=\"graphic graphic_picture graphicRef103618 \">picture 7</a>) [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/38,39\" class=\"abstract_t\">38,39</a>]. Revertant mosaicism, also called &quot;spontaneous gene repair&quot; or &quot;natural gene therapy,&quot; has been documented in several genetic disorders involving organs that undergo self-regeneration, including the skin and in all types of epidermolysis bullosa [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/40\" class=\"abstract_t\">40</a>]. In patients with Kindler syndrome, revertant patches can be recognized as soon as the affected skin becomes atrophic. Revertant areas are stable in time and preserve a normal skin texture, in contrast to the surrounding atrophic skin (<a href=\"image.htm?imageKey=DERM%2F103618\" class=\"graphic graphic_picture graphicRef103618 \">picture 7</a>).</p><p class=\"headingAnchor\" id=\"H131800603\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathology of Kindler syndrome skin shows epidermal atrophy and hyperkeratosis, microblisters at the dermal-epidermal junction, presence of sunburn cells, and pigment incontinence. In the dermis, there are dilated vessels and fragmented and sparse elastic fibers (<a href=\"image.htm?imageKey=DERM%2F103619\" class=\"graphic graphic_picture graphicRef103619 \">picture 8</a>).</p><p class=\"headingAnchor\" id=\"H131800609\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H71742370\"><span class=\"h2\">Clinical suspicion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In neonates, the diagnosis of Kindler syndrome cannot be suspected clinically, since blistering cannot be distinguished from other types of epidermolysis bullosa [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. In older children, the coexistence of skin blistering, photosensitivity, and cigarette-paper-like atrophy on the dorsal aspects of the hands raise the suspicion of Kindler syndrome. In adults, poikiloderma in conjunction with a history of blistering and photosensitivity during childhood suggests the diagnosis.</p><p class=\"headingAnchor\" id=\"H131800635\"><span class=\"h2\">Biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A 2 to 4 mm punch biopsy taken from a freshly induced blister is the first step in the diagnosis of inherited bullous diseases. The technique for obtaining and processing an optimal specimen for immunofluorescence microscopy <span class=\"nowrap\">and/or</span> transmission electron microscopy is discussed in detail elsewhere. (See <a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa#H2394298\" class=\"medical medical_review\">&quot;Diagnosis of epidermolysis bullosa&quot;, section on 'Obtaining biopsies for EB diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H156820277\"><span class=\"h3\">Transmission electron microscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In Kindler syndrome, the level of skin cleavage is variable, intraepidermal and subepidermal, and can be discriminated by transmission electron microscopy. This technique demonstrates splits within the basal keratinocytes, in the lamina lucida <span class=\"nowrap\">and/or</span> below the lamina densa, as well as reduplications and branches of the lamina densa of the basement membrane [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. However, transmission electron microscopy is not widely accessible and interpretation requires special expertise.</p><p class=\"headingAnchor\" id=\"H156820283\"><span class=\"h3\">Immunofluorescence antigen mapping</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunofluorescence staining with antibodies to components of the dermal-epidermal junction zone (eg, bullous pemphigoid-1 antigen, laminin-332, collagen IV, keratin 14) may be employed alternatively as a first diagnostic step in patients with suspected Kindler syndrome. This procedure, also known as antigen mapping or immunofluorescence mapping, is widely used for the diagnostics of other types of epidermolysis bullosa [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/41-43\" class=\"abstract_t\">41-43</a>]. (See <a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa#H2394305\" class=\"medical medical_review\">&quot;Diagnosis of epidermolysis bullosa&quot;, section on 'Immunofluorescence microscopy'</a>.)</p><p>In Kindler syndrome skin, microblisters at the dermal-epidermal junction are indicated by discontinuous staining of markers such as type IV collagen or laminin-332. An irregular, broad staining pattern of laminin-332 and type VII collagen is highly suggestive of the diagnosis (<a href=\"image.htm?imageKey=DERM%2F103627\" class=\"graphic graphic_picture graphicRef103627 \">picture 9</a>) [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/44\" class=\"abstract_t\">44</a>].</p><p>A negative staining with antibodies to kindlin-1 would specifically indicate the absence of this protein in the patient's skin. However, the available antibodies are not suitable for diagnosis, due to a high background staining with only a faint specific signal.</p><p class=\"headingAnchor\" id=\"H131800641\"><span class=\"h2\">Mutation analysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mutation analysis represents the gold standard for the diagnosis of Kindler syndrome. More than 70 distinct <em>FERMT1</em> mutations have been reported (<a href=\"http://www.hgmd.cf.ac.uk/ac/index.php&amp;token=w7p0LC3/+c5TTfDIkVSPKuXOHlNonGDNq2foBOcxWHjS2ipCxB5EMN1sOeOrxH2h&amp;TOPIC_ID=15510\" target=\"_blank\" class=\"external\">Human Gene Mutation Database [HGMD]</a>; <a href=\"https://grenada.lumc.nl/LOVD2/mendelian_genes/variants.php?action=view_all&amp;token=4YQ9Z5FUp70OHSrvIBc62i6d/wOHHZJM2uIBPyJ0yLJ4qaPHdypQ3cA8RtguYoAJPXPjx6vHGYRUlpLAKdgR5r1D//HsQm15qJXu37HaWfmvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=15510\" target=\"_blank\" class=\"external\">Leiden Open Variation Database [LOVD]</a>). Mutation analysis may be performed as candidate gene testing or by using targeted gene panel or whole exome next-generation sequencing (NGS)-based analyses. (See <a href=\"topic.htm?path=next-generation-dna-sequencing-ngs-principles-and-clinical-applications\" class=\"medical medical_review\">&quot;Next-generation DNA sequencing (NGS): Principles and clinical applications&quot;</a>.)</p><p>Because of the diverse mutational mechanisms, additional tests, such as quantitative real-time polymerase chain reaction (PCR), multiplex ligation-dependent probe amplification (MLPA), or RNA sequencing, may be required to disclose mutations. Whole-exome sequencing may also be employed, but will not capture particular types of mutations for which whole-genome sequencing or RNA sequencing are required. Genetically unsolved cases may be due to particular mutations in regions of <em>FERMT1</em> that are not covered by routine diagnostic procedures [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H131800653\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In children and adults, the differential diagnosis of Kindler syndrome includes other types of epidermolysis bullosa and poikilodermatous and sclerotic disorders.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dystrophic epidermolysis bullosa</strong> &ndash; In many patients with Kindler syndrome, the diagnosis of dystrophic epidermolysis bullosa is first considered, based upon the presence of blistering, scarring, esophageal stenosis, and abnormal staining of collagen type VII in the skin. The clinical assessment of skin atrophy, photosensitivity, poikiloderma, and gingivitis may help to distinguish the two disorders. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa#H2900750\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;, section on 'Dystrophic epidermolysis bullosa'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Junctional epidermolysis bullosa</strong> &ndash; A distinct subtype of late-onset junctional epidermolysis bullosa caused by specific mutations in the gene for collagen XVII may present with clinical features that resemble Kindler syndrome, in particular mild blistering, progressive skin atrophy, and irregular deposition of markers of the dermal-epidermal junction zone [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/45\" class=\"abstract_t\">45</a>]. Features that support the diagnosis of junctional epidermolysis bullosa include nail loss, lack of photosensitivity, and the demonstration of the amino-acid substitution p.R1303Q in collagen XVII [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa#H2900721\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;, section on 'Junctional epidermolysis bullosa'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Epidermolysis bullosa simplex</strong> &ndash; Patients with Kindler syndrome are sometimes initially diagnosed with epidermolysis bullosa simplex, which shares some clinical features with Kindler syndrome, such as mild acral blistering that improves with age. The identification of additional clinical and molecular characteristics of Kindler syndrome allows the correct diagnosis. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa#H2900707\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;, section on 'Epidermolysis bullosa simplex'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dyskeratosis congenita</strong> &ndash; Dyskeratosis congenita is an inherited bone marrow failure syndrome associated with poikiloderma, palmoplantar hyperkeratosis, mucosal involvement, and predisposition to cancer (<a href=\"image.htm?imageKey=PEDS%2F76566\" class=\"graphic graphic_picture graphicRef76566 \">picture 10</a> and <a href=\"image.htm?imageKey=PEDS%2F81497\" class=\"graphic graphic_table graphicRef81497 \">table 1</a>). Detailed history, careful clinical assessment, and laboratory work-up allow the discrimination of the two entities. (See <a href=\"topic.htm?path=dyskeratosis-congenita-and-other-short-telomere-syndromes\" class=\"medical medical_review\">&quot;Dyskeratosis congenita and other short telomere syndromes&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Rothmund-Thomson syndrome</strong> &ndash; Rothmund-Thomson syndrome is characterized by poikiloderma; sparse hair, eyelashes, <span class=\"nowrap\">and/or</span> eyebrows; small stature; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/46\" class=\"abstract_t\">46</a>]. Detailed history and careful clinical assessment allow the discrimination of the two entities.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Poikiloderma with neutropenia, Clericuzio type</strong> &ndash; Poikiloderma with neutropenia, Clericuzio type (MIM #604173)&nbsp;is a rare autosomal recessive genodermatosis characterized by poikiloderma, chronic neutropenia, recurrent pulmonary infections, short stature, facial dysmorphism, pachyonychia, palmoplantar keratoderma, and skeletal defects [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/47-50\" class=\"abstract_t\">47-50</a>]. The disease, initially described in Navajo Native Americans, is caused by mutations in the <em>C16orf57</em> gene on 16q13 [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/49,51\" class=\"abstract_t\">49,51</a>]. Patients present with a papular erythematous rash on the limbs during the first year of life that results in progressive poikiloderma. Kindler syndrome may be initially suspected in patients with poikiloderma with neutropenia, but lack of blistering and the presence of neutropenia should discriminate these two entities.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Systemic sclerosis</strong> &ndash; Mild phenotypes of Kindler syndrome may be misdiagnosed as systemic sclerosis, based upon the presence of mucocutaneous findings such as sclerotic fingers, microstomia, and esophageal stenosis [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/33,52\" class=\"abstract_t\">33,52</a>]. Detailed history, careful clinical examination, and the demonstration of a <em>FERMT1</em> mutation lead to the correct diagnosis. (See <a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-sclerosis-scleroderma-in-adults\" class=\"medical medical_review\">&quot;Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults&quot;</a> and <a href=\"topic.htm?path=juvenile-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">&quot;Juvenile systemic sclerosis (scleroderma)&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H131800659\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no specific treatment for Kindler syndrome. There are no experimental targeted therapies such as gene, cell, or protein therapy envisioned so far to replace kindlin-1. Genotype-phenotype correlation studies suggest that increasing the expression of kindlin-1 by approximately 10 percent would significantly alleviate the phenotype [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/19\" class=\"abstract_t\">19</a>]. Experimental evidence for potential benefit from antioxidant therapies needs to be translated into clinical trials [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/18,20\" class=\"abstract_t\">18,20</a>].</p><p>The management is largely supportive and involves an interdisciplinary team for the treatment of the complications that occur progressively, such as limited mobility of fingers, esophageal and urethral stenoses, conjunctivitis, and severe periodontitis. (See <a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Overview of the management of epidermolysis bullosa&quot;</a>.)</p><p>The management strategy involves the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>General skin care measures, including avoidance of mechanical trauma and frequent use of moisturizers; for blisters and erosions, antiseptics and nonadhesive wound dressings should be employed [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/53\" class=\"abstract_t\">53</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients should be educated to adopt photoprotection measures, even if they do not manifest photosensitivity. (See <a href=\"topic.htm?path=selection-of-sunscreen-and-sun-protective-measures\" class=\"medical medical_review\">&quot;Selection of sunscreen and sun-protective measures&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Careful and regular dental care is mandatory to prevent the development of periodontitis [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/54\" class=\"abstract_t\">54</a>]. Mechanical pressure and irritations of the oral mucosa should be avoided, since they may contribute to inflammation and carcinogenesis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eye care and regular ophthalmologic evaluation is an important part of the management of patients with Kindler syndrome, particularly for patients who develop ectropion [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/55\" class=\"abstract_t\">55</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophageal and urethral stenosis may require repeated dilatations.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Caloric supplementation and fluid diet should be considered if body mass index is reduced due to difficulties in eating and swallowing.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hand surgery may be required for pseudoainhum and pseudosyndactyly. Revertant skin patches can be used for grafting.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients should undergo regular total-body skin examinations for early detection of skin cancer, starting at the age of 20 years [<a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/56\" class=\"abstract_t\">56</a>].</p><p/><p class=\"headingAnchor\" id=\"H131800665\"><span class=\"h1\">PROGNOSIS AND FOLLOW-UP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with Kindler syndrome can have a normal life expectancy. Complications such as limited mobility of fingers, esophageal and urethral stenoses, conjunctivitis, and severe periodontitis are frequent and require ongoing care. The prognosis may be poor for patients who develop invasive mucocutaneous squamous cell carcinomas. Close clinical surveillance for early detection of mucocutaneous malignancies is therefore of key importance for these patients.</p><p>We examine patients with Kindler syndrome once a year to adjust skin care and detect complications. A closer follow-up is indicated for patients treated for a mucocutaneous squamous cell carcinoma. The frequency of examinations may vary for the individual patient, based upon the extent of disease and the clinician's assessment of the risk for recurrence. (See <a href=\"topic.htm?path=recognition-and-management-of-high-risk-aggressive-cutaneous-squamous-cell-carcinoma#H90084886\" class=\"medical medical_review\">&quot;Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma&quot;, section on 'Follow-up'</a> and <a href=\"topic.htm?path=posttreatment-surveillance-of-squamous-cell-carcinoma-of-the-head-and-neck\" class=\"medical medical_review\">&quot;Posttreatment surveillance of squamous cell carcinoma of the head and neck&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H131800677\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Kindler syndrome is a rare autosomal recessive type of epidermolysis bullosa characterized by skin blistering, photosensitivity, progressive poikiloderma, extensive skin atrophy, and squamous cell carcinomas of skin and mucosal membranes. (See <a href=\"#H131800537\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Kindler syndrome is caused by a broad spectrum of mutations of the <em>FERMT1</em> gene, encoding kindlin-1, an epithelial-specific protein expressed in the skin, periodontal tissues, and colon. (See <a href=\"#H131800549\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin blistering is usually present at birth with acral distribution (<a href=\"image.htm?imageKey=DERM%2F103491\" class=\"graphic graphic_picture graphicRef103491 \">picture 1</a>) and tends to decrease with age. Skin atrophy beginning on the dorsal aspects of the hands and feet (<a href=\"image.htm?imageKey=DERM%2F103492\" class=\"graphic graphic_picture graphicRef103492 \">picture 2</a>) starts in infancy or early childhood. In adults, the main cutaneous findings are poikiloderma (<a href=\"image.htm?imageKey=DERM%2F103494\" class=\"graphic graphic_picture graphicRef103494 \">picture 3</a>) and mucocutaneous scarring, leading to stenoses of the esophagus and genitourinary tract, ectropion, and webbing of fingers. (See <a href=\"#H131800561\" class=\"local\">'Clinical manifestations and natural history'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The evaluation of a skin biopsy of a freshly induced blister by immunofluorescence microscopy or transmission electron microscopy is the first step in the diagnosis of Kindler syndrome. The diagnosis is confirmed by the demonstration of mutations in the <em>FERMT1</em> gene. (See <a href=\"#H131800609\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no specific treatment for Kindler syndrome. The management is largely supportive and involves an interdisciplinary team for the treatment of the complications that occur progressively, such as limited mobility of fingers, esophageal and urethral stenoses, conjunctivitis, and severe periodontitis. All patients should adopt strict photoprotection measures and undergo regular skin examination for early detection of skin cancer starting in early adulthood. (See <a href=\"#H131800659\" class=\"local\">'Management'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/1\" class=\"nounderline abstract_t\">Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/2\" class=\"nounderline abstract_t\">Penagos H, Jaen M, Sancho MT, et al. Kindler syndrome in native Americans from Panama: report of 26 cases. Arch Dermatol 2004; 140:939.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/3\" class=\"nounderline abstract_t\">Youssefian L, Vahidnezhad H, Barzegar M, et al. The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families. J Invest Dermatol 2015; 135:1447.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/4\" class=\"nounderline abstract_t\">Jobard F, Bouadjar B, Caux F, et al. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet 2003; 12:925.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/5\" class=\"nounderline abstract_t\">Siegel DH, Ashton GH, Penagos HG, et al. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet 2003; 73:174.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/6\" class=\"nounderline abstract_t\">Zhan J, Yang M, Zhang J, et al. Kindler syndrome protein Kindlin-1 is mainly expressed in adult tissues originating from ectoderm/endoderm. Sci China Life Sci 2015; 58:432.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/7\" class=\"nounderline abstract_t\">Petricca G, Leppilampi M, Jiang G, et al. Localization and potential function of kindlin-1 in periodontal tissues. Eur J Oral Sci 2009; 117:518.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/8\" class=\"nounderline abstract_t\">Herz C, Aumailley M, Schulte C, et al. Kindlin-1 is a phosphoprotein involved in regulation of polarity, proliferation, and motility of epidermal keratinocytes. J Biol Chem 2006; 281:36082.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/9\" class=\"nounderline abstract_t\">Kern JS, Herz C, Haan E, et al. Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoforms. J Pathol 2007; 213:462.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/10\" class=\"nounderline abstract_t\">Karak&ouml;se E, Schiller HB, F&auml;ssler R. The kindlins at a glance. J Cell Sci 2010; 123:2353.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/11\" class=\"nounderline abstract_t\">Margadant C, Kreft M, Zambruno G, Sonnenberg A. Kindlin-1 regulates integrin dynamics and adhesion turnover. PLoS One 2013; 8:e65341.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/12\" class=\"nounderline abstract_t\">Patel H, Stavrou I, Shrestha RL, et al. Kindlin1 regulates microtubule function to ensure normal mitosis. J Mol Cell Biol 2016; 8:338.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/13\" class=\"nounderline abstract_t\">Qu H, Wen T, Pesch M, Aumailley M. Partial loss of epithelial phenotype in kindlin-1-deficient keratinocytes. Am J Pathol 2012; 180:1581.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/14\" class=\"nounderline abstract_t\">Shen C, Sun L, Zhu N, Qi F. Kindlin-1 contributes to EGF-induced re-epithelialization in skin wound healing. Int J Mol Med 2017; 39:949.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/15\" class=\"nounderline abstract_t\">Patel H, Zich J, Serrels B, et al. Kindlin-1 regulates mitotic spindle formation by interacting with integrins and Plk-1. Nat Commun 2013; 4:2056.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/16\" class=\"nounderline abstract_t\">Rognoni E, Widmaier M, Jakobson M, et al. Kindlin-1 controls Wnt and TGF-&beta; availability to regulate cutaneous stem cell proliferation. Nat Med 2014; 20:350.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/17\" class=\"nounderline abstract_t\">Zhang X, Luo S, Wu J, et al. KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage. J Invest Dermatol 2017; 137:475.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/18\" class=\"nounderline abstract_t\">Maier K, He Y, W&ouml;lfle U, et al. UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome. Hum Mol Genet 2016; 25:5339.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/19\" class=\"nounderline abstract_t\">Maier K, He Y, Esser PR, et al. Single Amino Acid Deletion in Kindlin-1 Results in Partial Protein Degradation Which Can Be Rescued by Chaperone Treatment. J Invest Dermatol 2016; 136:920.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/20\" class=\"nounderline abstract_t\">Emmert H, Patel H, Brunton VG. Kindlin-1 protects cells from oxidative damage through activation of ERK signalling. Free Radic Biol Med 2017; 108:896.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/21\" class=\"nounderline abstract_t\">Heinemann A, He Y, Zimina E, et al. Induction of phenotype modifying cytokines by FERMT1 mutations. Hum Mutat 2011; 32:397.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/22\" class=\"nounderline abstract_t\">Techanukul T, Sethuraman G, Zlotogorski A, et al. Novel and recurrent FERMT1 gene mutations in Kindler syndrome. Acta Derm Venereol 2011; 91:267.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/23\" class=\"nounderline abstract_t\">Has C, Ludwig RJ, Herz C, et al. C-terminally truncated kindlin-1 leads to abnormal adhesion and migration of keratinocytes. Br J Dermatol 2008; 159:1192.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/24\" class=\"nounderline abstract_t\">Has C, Chmel N, Levati L, et al. FERMT1 promoter mutations in patients with Kindler syndrome. Clin Genet 2015; 88:248.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/25\" class=\"nounderline abstract_t\">Chmel N, Danescu S, Gruler A, et al. A Deep-Intronic FERMT1 Mutation Causes Kindler Syndrome: An Explanation for Genetically Unsolved Cases. J Invest Dermatol 2015; 135:2876.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/26\" class=\"nounderline abstract_t\">Fuchs-Telem D, Nousbeck J, Singer A, et al. New intragenic and promoter region deletion mutations in FERMT1 underscore genetic homogeneity in Kindler syndrome. Clin Exp Dermatol 2014; 39:361.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/27\" class=\"nounderline abstract_t\">Krishna CV, Parmar NV, Has C. Kindler syndrome with severe mucosal involvement in childhood. Clin Exp Dermatol 2014; 39:340.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/28\" class=\"nounderline abstract_t\">El Hachem M, Diociaiuti A, Proto V, et al. Kindler syndrome with severe mucosal involvement in a large Palestinian pedigree. Eur J Dermatol 2015; 25:14.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/29\" class=\"nounderline abstract_t\">Wiebe CB, Petricca G, H&auml;kkinen L, et al. Kindler syndrome and periodontal disease: review of the literature and a 12-year follow-up case. J Periodontol 2008; 79:961.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/30\" class=\"nounderline abstract_t\">Wiebe CB, Penagos H, Luong N, et al. Clinical and microbiologic study of periodontitis associated with Kindler syndrome. J Periodontol 2003; 74:25.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/31\" class=\"nounderline abstract_t\">Has C, Castiglia D, del Rio M, et al. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum Mutat 2011; 32:1204.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/32\" class=\"nounderline abstract_t\">Shimizu S, Nishie W, Tsuchiya K, et al. Kindler syndrome with severe intestinal involvement: a 31-year follow-up. Acta Derm Venereol 2014; 94:351.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/33\" class=\"nounderline abstract_t\">Mansur AT, Elcioglu NH, Ayding&ouml;z IE, et al. Novel and recurrent KIND1 mutations in two patients with Kindler syndrome and severe mucosal involvement. Acta Derm Venereol 2007; 87:563.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/34\" class=\"nounderline abstract_t\">Ezzine Seba&iuml; N, Trojjet S, Khaled A, et al. [Kindler syndrome: three cases reports in three siblings]. Ann Dermatol Venereol 2007; 134:774.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/35\" class=\"nounderline abstract_t\">Hayashi S, Shimoya K, Itami S, Murata Y. Pregnancy and delivery with Kindler syndrome. Gynecol Obstet Invest 2007; 64:72.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/36\" class=\"nounderline abstract_t\">Lelli GJ Jr. Kindler syndrome causing severe cicatricial ectropion. Ophthal Plast Reconstr Surg 2010; 26:368.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/37\" class=\"nounderline abstract_t\">Arita K, Wessagowit V, Inamadar AC, et al. Unusual molecular findings in Kindler syndrome. Br J Dermatol 2007; 157:1252.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/38\" class=\"nounderline abstract_t\">Lai-Cheong JE, Moss C, Parsons M, et al. Revertant mosaicism in Kindler syndrome. J Invest Dermatol 2012; 132:730.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/39\" class=\"nounderline abstract_t\">Kiritsi D, He Y, Pasmooij AM, et al. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest 2012; 122:1742.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/40\" class=\"nounderline abstract_t\">Pasmooij AM, Jonkman MF, Uitto J. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. Discov Med 2012; 14:167.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/41\" class=\"nounderline abstract_t\">Hintner H, Stingl G, Schuler G, et al. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J Invest Dermatol 1981; 76:113.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/42\" class=\"nounderline abstract_t\">Pohla-Gubo G, Cepeda-Valdes R, Hintner H. Immunofluorescence mapping for the diagnosis of epidermolysis bullosa. Dermatol Clin 2010; 28:201.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/43\" class=\"nounderline abstract_t\">Has C, He Y. Research Techniques Made Simple: Immunofluorescence Antigen Mapping in Epidermolysis Bullosa. J Invest Dermatol 2016; 136:e65.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/44\" class=\"nounderline abstract_t\">Lai-Cheong JE, McGrath JA. Kindler syndrome. Dermatol Clin 2010; 28:119.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/45\" class=\"nounderline abstract_t\">Has C, Kiritsi D, Mellerio JE, et al. The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome. J Invest Dermatol 2014; 134:845.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/46\" class=\"nounderline abstract_t\">Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis 2010; 5:2.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/47\" class=\"nounderline abstract_t\">Koparir A, Gezdirici A, Koparir E, et al. Poikiloderma with neutropenia: genotype-ethnic origin correlation, expanding phenotype and literature review. Am J Med Genet A 2014; 164A:2535.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/48\" class=\"nounderline abstract_t\">Van Hove JL, Jaeken J, Proesmans M, et al. Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome. Am J Med Genet A 2005; 132A:152.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/49\" class=\"nounderline abstract_t\">Arnold AW, Itin PH, Pigors M, et al. Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria. Br J Dermatol 2010; 163:866.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/50\" class=\"nounderline abstract_t\">Mostefai R, Morice-Picard F, Boralevi F, et al. Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco. Am J Med Genet A 2008; 146A:2762.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/51\" class=\"nounderline abstract_t\">Volpi L, Roversi G, Colombo EA, et al. Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet 2010; 86:72.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/52\" class=\"nounderline abstract_t\">Has C, Burger B, Volz A, et al. Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology 2010; 221:309.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/53\" class=\"nounderline abstract_t\">El Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis 2014; 9:76.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/54\" class=\"nounderline abstract_t\">Kr&auml;mer SM, Serrano MC, Zillmann G, et al. Oral health care for patients with epidermolysis bullosa--best clinical practice guidelines. Int J Paediatr Dent 2012; 22 Suppl 1:1.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/55\" class=\"nounderline abstract_t\">Figueira EC, Murrell DF, Coroneo MT. Ophthalmic involvement in inherited epidermolysis bullosa. Dermatol Clin 2010; 28:143.</a></li><li><a href=\"https://www.uptodate.com/contents/kindler-syndrome/abstract/56\" class=\"nounderline abstract_t\">Mellerio JE, Robertson SJ, Bernardis C, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol 2016; 174:56.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 15510 Version 6.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H131800677\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H131800537\" id=\"outline-link-H131800537\">INTRODUCTION</a></li><li><a href=\"#H131800543\" id=\"outline-link-H131800543\">EPIDEMIOLOGY</a></li><li><a href=\"#H131800549\" id=\"outline-link-H131800549\">PATHOGENESIS</a><ul><li><a href=\"#H71742176\" id=\"outline-link-H71742176\">Kindlin-1 protein</a></li><li><a href=\"#H131800555\" id=\"outline-link-H131800555\">Genetics</a></li></ul></li><li><a href=\"#H131800561\" id=\"outline-link-H131800561\">CLINICAL MANIFESTATIONS AND NATURAL HISTORY</a><ul><li><a href=\"#H131800567\" id=\"outline-link-H131800567\">Skin lesions</a></li><li><a href=\"#H131800573\" id=\"outline-link-H131800573\">Hair and nail changes</a></li><li><a href=\"#H131800585\" id=\"outline-link-H131800585\">Mucosal lesions</a></li><li><a href=\"#H131800591\" id=\"outline-link-H131800591\">Mucocutaneous malignancies</a></li><li><a href=\"#H131800597\" id=\"outline-link-H131800597\">Revertant mosaicism</a></li></ul></li><li><a href=\"#H131800603\" id=\"outline-link-H131800603\">PATHOLOGY</a></li><li><a href=\"#H131800609\" id=\"outline-link-H131800609\">DIAGNOSIS</a><ul><li><a href=\"#H71742370\" id=\"outline-link-H71742370\">Clinical suspicion</a></li><li><a href=\"#H131800635\" id=\"outline-link-H131800635\">Biopsy</a><ul><li><a href=\"#H156820277\" id=\"outline-link-H156820277\">- Transmission electron microscopy</a></li><li><a href=\"#H156820283\" id=\"outline-link-H156820283\">- Immunofluorescence antigen mapping</a></li></ul></li><li><a href=\"#H131800641\" id=\"outline-link-H131800641\">Mutation analysis</a></li></ul></li><li><a href=\"#H131800653\" id=\"outline-link-H131800653\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H131800659\" id=\"outline-link-H131800659\">MANAGEMENT</a></li><li><a href=\"#H131800665\" id=\"outline-link-H131800665\">PROGNOSIS AND FOLLOW-UP</a></li><li><a href=\"#H131800677\" id=\"outline-link-H131800677\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/15510|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/103177\" class=\"graphic graphic_figure\">- Focal adhesions and kindlin-1 protein</a></li></ul></li><li><div id=\"DERM/15510|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/103491\" class=\"graphic graphic_picture\">- Kindler syndrome newborn</a></li><li><a href=\"image.htm?imageKey=DERM/103492\" class=\"graphic graphic_picture\">- Kindler syndrome skin atrophy</a></li><li><a href=\"image.htm?imageKey=DERM/103494\" class=\"graphic graphic_picture\">- Kindler syndrome poikiloderma</a></li><li><a href=\"image.htm?imageKey=DERM/103496\" class=\"graphic graphic_picture\">- Kindler syndrome hand sclerosis</a></li><li><a href=\"image.htm?imageKey=DERM/103497\" class=\"graphic graphic_picture\">- Kindler syndrome loss of dermatoglyphics</a></li><li><a href=\"image.htm?imageKey=DERM/103498\" class=\"graphic graphic_picture\">- Kindler syndrome nail dystrophy</a></li><li><a href=\"image.htm?imageKey=DERM/103568\" class=\"graphic graphic_picture\">- Kindler syndrome mucosal lesions</a></li><li><a href=\"image.htm?imageKey=DERM/103618\" class=\"graphic graphic_picture\">- Kindler syndrome revertant mosaicism</a></li><li><a href=\"image.htm?imageKey=DERM/103619\" class=\"graphic graphic_picture\">- Kindler syndrome histo</a></li><li><a href=\"image.htm?imageKey=DERM/103627\" class=\"graphic graphic_picture\">- Kindler syndrome IFM mapping</a></li><li><a href=\"image.htm?imageKey=PEDS/76566\" class=\"graphic graphic_picture\">- Dyskeratosis congenita</a></li></ul></li><li><div id=\"DERM/15510|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/81497\" class=\"graphic graphic_table\">- Physical anomalies associated with dyskeratosis congenita</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">Diagnosis of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dyskeratosis-congenita-and-other-short-telomere-syndromes\" class=\"medical medical_review\">Dyskeratosis congenita and other short telomere syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=juvenile-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Juvenile systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=next-generation-dna-sequencing-ngs-principles-and-clinical-applications\" class=\"medical medical_review\">Next-generation DNA sequencing (NGS): Principles and clinical applications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-sclerosis-scleroderma-in-adults\" class=\"medical medical_review\">Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">Overview of the management of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=periodontal-disease-in-children-associated-systemic-conditions\" class=\"medical medical_review\">Periodontal disease in children: Associated systemic conditions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=posttreatment-surveillance-of-squamous-cell-carcinoma-of-the-head-and-neck\" class=\"medical medical_review\">Posttreatment surveillance of squamous cell carcinoma of the head and neck</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=recognition-and-management-of-high-risk-aggressive-cutaneous-squamous-cell-carcinoma\" class=\"medical medical_review\">Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=selection-of-sunscreen-and-sun-protective-measures\" class=\"medical medical_review\">Selection of sunscreen and sun-protective measures</a></li></ul></div></div>","javascript":null}